4SC AG is a company headquartered in Germany.
4SC AG is a Germany-based biopharmaceutical company that discovers and develops small-molecule therapeutics, primarily for oncology. The company focuses on targeted kinase and epigenetic inhibitors and advances candidates through clinical development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.